GlassScriptPhysician profile
Allyson Farrah
NPI 1326668666
$13,622.01
in general payments reported to CMS, 2019-2025
15 companies · $6,463 in 2025
The $6,463 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $246 · 2022: $729 · 2023: $873 · 2024: $5,310 · 2025: $6,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,442 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,988 · Travel and Lodging: $3,208 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,441.73 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,988.00 |
| Travel and Lodging | $3,207.70 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,130.09 | 2022-2025 | Linq II, Aurora Ev-Icd Mri Surescan, Reveal Linq |
| Boston Scientific Corporation | $3,730.41 | 2022-2025 | General - Therapies, Watchman Flx, Emblem Mri S-Icd |
| Abbott Laboratories | $882.48 | 2023-2025 | Aveir, Amplatzer Amulet, Jot Dx |
| Biosense Webster, INC. | $267.83 | 2022-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $156.12 | 2021-2023 | Lifevest |
| Kestra Medical Technology Services, INC. | $104.98 | 2023 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $73.69 | 2024 | Optimizer |
| Janssen Pharmaceuticals, INC | $68.22 | 2022-2024 | Xarelto |
| Philips North America LLC | $53.23 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.22 | 2021 | |
| Bridgebio Pharma, INC. | $26.84 | 2025 | Attruby |
| Esperion Therapeutics, INC. | $21.96 | 2021 | |
| Pfizer INC. | $20.85 | 2025 | |
| Merck Sharp & Dohme LLC | $17.99 | 2021 | |
| Amgen INC. | $16.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Farrah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.